Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate versus dexmedetomidine for attenuation of hemodynamic response during skull pinning in elective neurosurgery
PACTR202511827595947Phase 4Not yet recruiting
- Sponsor
- Mario Ragaey Fakhry Doos
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in conditions requiring elective craniotomy comparing Magnesium sulfate arm with Dexmedetomidine arm (2 arms). Primary endpoint: Mean arterial pressure response during skull pin application. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
magnesium sulfatedexmedetomidine
03
Conditions
conditions requiring elective craniotomy
Beyond the preview
Go deeper on PACTR202511827595947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202511827595947.